MTOR and cholangiocarcinoma: With the improvement of cancer genome profiling technology, a variety of molecular alterations involving both oncogenes and tumor suppressor genes have been described in CCA [29], and most of the genetic alternations in dCCA involve PI3K/mTOR [6].